To provide a method of uncoupling mitochondria in a subject.
A method of uncoupling mitochondria in a subject including a step of administering nanotubes to the subject in a therapeutically effective amount, wherein the nanotubes are self-rectifying is provided. A method of decreasing reactive oxygen species and decreasing detrimental loading of Ca2+ into mitochondria is provided, including a step of administering a pharmaceutically effective amount of nanotubes into the subject, wherein the nanotubes are self-rectifying. A method of reducing weight, treating cancer, reducing the effects of traumatic brain injury, or reducing the effects of ageing, in a subject including administering a pharmaceutically effective amount of nanotubes into the subject is also provided.
WO2004041256A2 | 2004-05-21 | |||
US6613875B1 | 2003-09-02 |
JPN6011058507; Martin CR and Kohli P.: 'The emerging field of nanotube biotechnology.' Nat Rev Drug Discov. Vol.2 no.1, 200301, pp.29-37
JPN6011058504; Harper JA et al.: 'Mitochondrial uncoupling as a target for drug development for the treatment of obesity.' Obes Rev. Vol.2 no.4, 200111, pp.255-265
JPN6011058493; Martin CR et al.: 'Voltage gating in synthetic single-nanotube membranes.' Biophysical Journal, Vol.86 No.1, 200401, p.131a
JPN6011058495; 二木 史朗: '合成ペプチドによるイオンチャネル機能の創出' 有機合成化学協会誌 Vol.56 no.2, 1998, pp.125-133
JPN6011058498; Sullivan PG et al.: 'Mitochondrial uncoupling as a therapeutic target following neuronal injury.' J Bioenerg Biomembr. Vol.36 no.4, 200408, pp.353-356
JPN6011058502; Brown MR et al.: 'Brain region-specific, age-related, alterations in mitochondrial responses to elevated calcium.' J Bioenerg Biomembr. Vol.36 no.4, 200408, pp.401-406
JPN6011058507; Martin CR and Kohli P.: 'The emerging field of nanotube biotechnology.' Nat Rev Drug Discov. Vol.2 no.1, 200301, pp.29-37
Shiro Takayanagi
Yasuhiro Otsuka
Shuji Kimura
Osamu Shimoyama